AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS (EIN 231682043) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1900

Legal Domicile

Principal Officer

ABIGAIL W GORMAN

Phone

7038366981

Tax Period

2023-01-01 to 2023-12-31

AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS, founded in 1900, is a community nonprofit in the Health Care sector that reported $3.8M in total revenue in fiscal year 2018. Revenue grew 9% year-over-year, indicating healthy expansion. Expenses of $3.6M left a modest 6% surplus.

Mission

ADVANCING CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE AND THERAPEUTICS FOR THE BENEFIT OF PATIENTS AND SOCIETY. SIGNIFICANT ACTIVITIES INCLUDE THREE SCHOLARLY PEER-REVIEWED JOURNALS ALONG WITH ONLINE EDUCATIONAL OPPORTUNITIES.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $58,535

Program Service Revenue $3,514,192

Investment Income $120,233

Other Revenue $7,410

TOTAL REVENUE $3,700,370

Expense Breakdown

Grants Paid $60,495

Salaries & Benefits $1,870,957

Fundraising Expenses $0

Program Expenses $3,588,849

Other Expenses $2,122,107

TOTAL EXPENSES $4,053,559

Year-over-Year Comparison

	2023	2022	Change
Revenue	$3,700,370	$3,625,776	+0.0%
Expenses	$4,053,559	$3,254,073	+0.2%
Net Income	$-353,189	$371,703	-2.0%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

600

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$714,378

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
WALTER KRAFT	PRESIDENT	4.00	Officer Director	$0	$0	$0
MARK J DRESSER	IMMEDIATE PAST PRESIDENT	4.00	Officer Director	$0	$0	$0
MATTHEW L RIZK	PRESIDENT-ELECT	4.00	Officer Director	$0	$0	$0
JACQUES TURGEON	TREASURER	4.00	Officer Director	$0	$0	$0
ANTOINETTE TONI AJAVON-HARTMANN	DIRECTOR	4.00	Director	$0	$0	$0
LISA J BENINCOSA	DIRECTOR	4.00	Director	$0	$0	$0
JING LIU	DIRECTOR	4.00	Director	$0	$0	$0
KATHRYN MOMARY	DIRECTOR	4.00	Director	$0	$0	$0
DANIELE OUELLET	DIRECTOR	4.00	Director	$0	$0	$0
LUANA PESCO-KOPLOWITZ	DIRECTOR	4.00	Director	$0	$0	$0
ANU RAMAMOORTHY	DIRECTOR	4.00	Director	$0	$0	$0
ABIGAIL GORMAN	CHIEF EXECUTIVE OFFICER	40.00	Officer	$366,589	$41,665	$408,254
ELISE LAFFMAN-JOHNSON	CHIEF OPERATING OFFICER	40.00	Officer	$281,675	$24,449	$306,124
LISA INFELISE	SR DIR, MBR SVCS	40.00	Highest	$165,789	$24,191	$189,980
ALETHEA GERDING	MANAGING EDITOR	40.00	Highest	$143,521	$12,350	$155,871

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$3,700,370	$4,053,559	$6,491,449	$-353,189
2022	$3,625,776	$3,254,073	$6,502,007	$371,703
2021	$4,282,201	$3,287,407	$6,637,281	$994,794
2020	$2,105,682	$2,668,717	$5,298,284	$-563,035
2019	$4,011,186	$3,682,303	$5,817,074	$328,883
2018	$3,798,624	$3,575,493	$5,194,739	$223,131

AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS